Gene · 923
Papers1,942
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,942
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Longitudinal liver sampling in patients with chronic hepatitis B starting antiviral therapy reveals hepatotoxic CD8+ T cells. | J Clin Invest | 2023 | 36594467 | PubTator, text mining | PubMed |
| Can Molecular Classifications Help Tailor First-line Treatment of Metastatic Renal Cell Carcinoma? A Systematic Review of Available Models. | Eur Urol Open Sci | 2023 | 36573246 | PubTator, text mining | PubMed |
| Dysfunctions of innate and adaptive immune tumor microenvironment in Waldenström macroglobulinemia. | Int J Cancer | 2023 | 36533670 | PubTator, text mining | PubMed |
| Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection. | Emerg Microbes Infect | 2023 | 36408648 | PubTator, text mining | PubMed |
| Aorta- and liver-generated TMAO enhances trained immunity for increased inflammation via ER stress/mitochondrial ROS/glycolysis pathways. | JCI Insight | 2023 | 36394956 | PubTator, text mining | PubMed |
| Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort. | Cancer Res | 2023 | 36378845 | PubTator, text mining | PubMed |
| CD166-specific CAR-T cells potently target colorectal cancer cells. | Transl Oncol | 2023 | 36327697 | PubTator, text mining | PubMed |
| The effects and potential of microglial polarization and crosstalk with other cells of the central nervous system in the treatment of Alzheimer's disease. | Neural Regen Res | 2023 | 36254973 | PubTator, text mining | PubMed |
| Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma. | Clin Cancer Res | 2023 | 36112545 | PubTator, text mining | PubMed |
| Recent advances in immunotherapies for lupus nephritis. | Pediatr Nephrol | 2023 | 35778517 | PubTator, text mining | PubMed |
| Anti CD-6 Monoclonal Antibodies in the Management of Generalised Pustular Psoriasis. | Indian J Dermatol | 2022 | 36865872 | PubTator, text mining | PubMed |
| The 3Ps: A tool for coach observation. | Front Sports Act Living | 2022 | 36742150 | PubTator, text mining | PubMed |
| Identification and classification of distinct surface markers of T regulatory cells. | Front Immunol | 2022 | 36741366 | PubTator, text mining | PubMed |
| Single-cell profiling reveals distinct subsets of CD14+ monocytes drive blood immune signatures of active tuberculosis. | Front Immunol | 2022 | 36713384 | PubTator, text mining | PubMed |
| Plasma protein profiling analysis in patients with atrial fibrillation before and after three different ablation techniques. | Front Cardiovasc Med | 2022 | 36704472 | PubTator, text mining | PubMed |
| Anticancer properties of bromelain: State-of-the-art and recent trends. | Front Oncol | 2022 | 36698404 | PubTator, text mining | PubMed |
| Extracellular vesicles derived from different sources play various roles in diabetic retinopathy. | Front Endocrinol (Lausanne) | 2022 | 36686474 | PubTator, text mining | PubMed |
| Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer's disease. | Front Immunol | 2022 | 36685605 | PubTator, text mining | PubMed |
| Immunotherapy strategies and prospects for acute lung injury: Focus on immune cells and cytokines. | Front Pharmacol | 2022 | 36618910 | PubTator, text mining | PubMed |
| piRNA and miRNA Can Suppress the Expression of Multiple Sclerosis Candidate Genes. | Nanomaterials (Basel) | 2022 | 36615932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/923/papers?page=17